This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
COVID-19 in children with diabetes Resources

COVID-19 and Children With Diabetes - Updates, Unknowns, and Next Steps: First, Do No Extrapolation

Linda A. DiMeglio, Anastasia Albanese-O’Neill, Cynthia E. Muñoz, and David M. Maahs

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide pandemic has been devastating particularly for older adults and those from vulnerable groups, including racial and ethnic minority populations. Additionally, people with certain underlying medical conditions, including diabetes, are also at increased risk of severe illness from coronavirus disease 2019 (COVID19)(1,2). Some children experience significant disease(3), and pediatric deaths have been reported (4). Because “diabetes” (generally grouping together type 1 diabetes and type 2 diabetes) and chronically elevated hyperglycemia have been associated with worse outcomes in adults with COVID-19 (5), the pediatric community has voiced great concerns about risk and outcomes for children with diabetes. Read the full article here.


The Global Covidiab Registry - new-onset diabetes, and the Covid-19 Pandemic

In early 2020, there were sporadic reports on new-onset diabetes, both type 1 and type 2, in both children and adults with SARS-CoV-2 (COVID-19) infection. To date, all studies on the subject have been limited by small sample sizes and the fact a diagnosis of COVID-19 could not always be confirmed. In order to address these limitations, an International group of leading diabetes researchers set up a global registry of Covid-19–related diabetes, Its aim is to establish the extent, natural history and longer term outcomes of new-onset diabetes in the context of the pandemic. Read more about the Global Covidiab Registry here.


COVID-19 Diabetes Supply Chain Coalition

The pandemic has caused many problems for diabetes centres in less-resourced countries. Common themes are families struggling to buy sufficient food, lives imperilled (and sadly some lost) by late presentation of Diabetes Ketoacidosis (DKA) in existing cases, transport and distribution issues, need for PPE for health professionals and families, and emergency insulin and strip needs. Many centres, particularly those who cross-finance, are struggling to pay staff and provide care. Life for a Child (LFAC) and various other groups are helping with cash grants and other support, and Beyond Type 1, ISPAD and others are helping with information for health professionals and families.


Coronavirus Diabetes Working Group

COVID and Diabetes Working Group is a collaboration of JDRF, Beyond Type 1, ADA, ISPAD and others aimed to develop updates for current COVID recommendations (April edition); including the relationship of diabetes and COVID-19 outcomes, how to return to work or school safely and caring for those living with diabetes under some form of lock down, and adapting to a wider range of countries. ISPAD is represented by Anju Virmani (India), Eduardo Calliari (Brazil), Carine de Beaufort (Luxembourg), Jill Weissberg-Benchel (USA), Steven James (Australia), and Kim Donaghue (Chair). It is planned to develop regular updates over the next six months.


COVID-19 Outbreak & Pediatric Diabetes - Survey Results Online!

In 2020 will be remain in our memory as the year of pandemic with a huge impact on individuals, families, societies and healthcare. How have healthcare professionals and young people with diabetes in their care as well as their families perceived this? Learn more about it here.


New Guideline: "Diabetic Ketoacidosis in the time of COVID-19: Role of Subcutaneous insulin"

Executive summary: The International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus Guidelines 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA in young people. Intravenous infusion of insulin for treating DKA may necessitate intensive care unit admission in hospitals in some parts of the world. During the Coronavirus Disease 2019 (COVID-19) pandemic, ICU services may need to be prioritised for care of affected individuals. Download the full guideline here. 


ISPAD Summaries of Recommendations 

  • I Summary of recommendations regarding COVID-19 in children with diabetes here.
    • Access to the Arabic version here
    • Access to the Portuguese version here
    • Access to the Spanish version here  
  • II Summary of recommendations regarding COVID-19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice here.
    • Access to the Arabic version here
    • Access to the Portuguese version here
    • Access to the Spanish version here

ISPAD's President Video analyzing ISPAD's latest recommendations regarding COVID-19 and children with diabetes.


Useful Links  


Educational Webinars

  • JDRF is organizing educational webinars in response to the COVID-19 crisis and concerns of people with type 1 diabetes. Dr. David Maahs, ISPAD Secretary-General, shares lessons learned from the ISPAD Forum and ISPAD Statements on COVID-19. Watch the webinar here. 

  • Remote Care in COVID-19 Times Video: The COVID-19 pandemic forces us all to think creative in order to ensure the best care possible for all persons with diabetes (PwD). Supplies need to be guaranteed. Telemedecine or Digital Clinics may help to offer routine care. The Diabeter Team in The Netherlands has been a forerunner in this field. In this video the two co-founders share their experience with ISPAD. Watch the video here.



We have opened up a forum discussion for diabetes providers to discuss how the unprecedented global pandemic of COVID-19 is affecting their patients with diabetes. 

In order to comment or share your observations on COVID-19, please click here and sign in to your member profile. Click on “New Topic” in order to start a new discussion thread!

In order to subscribe to all future updates / comments in the COVID-19 Forum, simply click
here and select Forum Actions > Subscribe to Instant Updates.


Contact Us

ISPAD Executive Office
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin, Germany


Click the link below to join the Society!

Join Today!

Phone: +49 (0)30 24603-210
Fax: +49 (0)30 24603-200
Email: secretariat@ispad.or

Privacy Policy
Terms of Service
Legal Notice    


 © 2020 International Society for Pediatric and Adolescent Diabetes (ISPAD)

Association Management Software Powered by YourMembership  ::  Legal